|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1998-10-29
|
|
pubmed:abstractText |
Primary unresectable and locally advanced recurrent rectal cancer presents a significant clinical challenge. Local failure rates are high in both situations. Under such circumstances, there is a significant need to safely deliver tumoricidal doses of radiation in an attempt to improve local control. For this reason, we have incorporated a new approach utilizing high dose rate intraoperative radiation therapy (HDR-IORT).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
325-30
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9788411-Adenocarcinoma,
pubmed-meshheading:9788411-Adult,
pubmed-meshheading:9788411-Aged,
pubmed-meshheading:9788411-Aged, 80 and over,
pubmed-meshheading:9788411-Antidotes,
pubmed-meshheading:9788411-Antimetabolites, Antineoplastic,
pubmed-meshheading:9788411-Carcinoma, Squamous Cell,
pubmed-meshheading:9788411-Combined Modality Therapy,
pubmed-meshheading:9788411-Disease-Free Survival,
pubmed-meshheading:9788411-Female,
pubmed-meshheading:9788411-Fluorouracil,
pubmed-meshheading:9788411-Humans,
pubmed-meshheading:9788411-Intraoperative Period,
pubmed-meshheading:9788411-Leucovorin,
pubmed-meshheading:9788411-Male,
pubmed-meshheading:9788411-Middle Aged,
pubmed-meshheading:9788411-Neoplasm Recurrence, Local,
pubmed-meshheading:9788411-Radiotherapy Dosage,
pubmed-meshheading:9788411-Rectal Neoplasms
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA.
|
|
pubmed:publicationType |
Journal Article
|
